|
Concomitant medical products: product id: 5076-52 lead, (b)(6) 2018.Product event summary: the device was returned and analyzed.Analysis of the returned device was inconclusive.Hybrid analysis determined the serious memory error was caused by the device reverting to running back-up firmware (bubu mode).The device entered bubu mode on (b)(6) 2020 due to the cumulative power on reset (por) threshold being met.The explant date was (b)(6) 2019.No root cause for the pors was confirmed and no new pors were noted.No hybrid anomalies were identified.If information is provided in the future, a supplemental report will be issued.
|
|
Product analysis #(b)(4):(b)(6)/ wed (b)(6) 2021 07:39:41 gmt-0600 central standard time analysis summary for pe#: (b)(4) analysis transaction id#: (b)(4) model#: w1sr01, serial/lot#: (b)(6).Methodology and techniques: the actual product involved in the event was evaluated.Electrical tests were performed.Mechanical tests were performed.Visual analysis was performed.Summary of analysis performed: during analysis, the following tests were performed: device - final analysis, and device - preliminary analysis.Results of analysis: based on analysis, it was determined the product failed to meet a performance specification.Product disposition: the returned product was retained in storage after the analysis concluded according to storage guidelines the product may be stored off site.If requested, the product may be returned to the patient provided after analysis the product was in a condition that it could be returned to the patient.Analysis information -- (b)(6) 2020 07:54:09 cst pli# 10 product id# w1sr01 the device was returned and analyzed.Analysis of the returned device was inconclusive.Hybrid analysis determined the serious memory error was caused by the device reverting to running back-up firmware (bubu mode).The device entered bubu mode on (b)(6) 2020 due to the cumulative power on reset (por) threshold being met.The explant date was (b)(6) 2019.No root cause for the pors was confirmed and no new pors were noted.No hybrid anomalies were identified.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|